UCITS Fund
ABARIS BIOTECHNOLOGY OPPORTUNITIES
Supervised by the CSSF · active
Abaris Biotechnology Opportunities is a UCITS fund regulated by the CSSF (Commission de Surveillance du Secteur Financier). It holds an active UCI licence granted under the Law of 17 December 2010, with that licence recorded as effective from 30 October 2020. The fund is classified within the UCI category, which covers undertakings for collective investment authorised and supervised under Luxembourg investment fund legislation. The CSSF maintains this fund in its official public register as an authorised UCI. No registered address is recorded in the available CSSF register data, no LEI has been assigned, and no RCS registration number is on record for this entity.
Key facts
- Fund structure
- UCITS Fund
- RCS number
- —
- LEI
- —
- Regulatory regime
- UCI (Law of 17 December 2010)
- Authorised since
- 30 October 2020
- Registered address
- —
Verify ABARIS BIOTECHNOLOGY OPPORTUNITIES on the official CSSF register ↗
About ABARIS BIOTECHNOLOGY OPPORTUNITIES
Authorised as a UCITS fund under the Law of 17 December 2010, Abaris Biotechnology Opportunities falls within the UCI licence category administered by the CSSF. This category encompasses collective investment undertakings that meet the requirements set out in Luxembourg's transposition of EU UCITS directives, subjecting them to ongoing regulatory oversight covering fund organisation, investor protection, and asset eligibility rules.
The fund's licence became effective on 30 October 2020, according to data held in the CSSF's official register. That date reflects the point at which authorisation was granted, not necessarily the date on which the fund began active investment operations. The licence status is recorded as active, indicating the fund remains in good standing with its regulator.
The name Abaris Biotechnology Opportunities suggests a focus on the biotechnology sector, though no specific investment policy, target market, or service scope is detailed in the CSSF register data available for this profile. No registered address has been specified in the source data, and no Legal Entity Identifier has been assigned to this fund. An LEI is a standardised 20-character code used in regulatory reporting and financial transaction records; its absence here means the fund cannot be cross-referenced through global LEI databases at this time. No RCS number is recorded, which may reflect the structure of the fund or the stage of its registration.
All data presented in this profile is drawn exclusively from the CSSF's official public register and reflects the information on record at the time of publication.